{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:20:01Z","timestamp":1785468001207,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jasc.2024.08.130","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T18:22:41Z","timestamp":1725042161000},"page":"413-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cytologic testing for mismatch repair deficiency\/microsatellite instability and NTRK gene fusion is not routinely indicated in primary pancreaticobiliary carcinoma cell block material"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0300-0697","authenticated-orcid":false,"given":"Courtney F.","family":"Connelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Towne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6610-8637","authenticated-orcid":false,"given":"Niyati","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6706-0700","authenticated-orcid":false,"given":"Marie C.","family":"Smithgall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Cimic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6362-1043","authenticated-orcid":false,"given":"Swikrity U.","family":"Baskota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2024.08.130_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000267","article-title":"Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages","volume":"7","author":"Gillen","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.jasc.2024.08.130_bib2","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1053\/j.gastro.2019.02.037","article-title":"Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers","volume":"156","author":"Singhi","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jasc.2024.08.130_bib3","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/jpm12111870","article-title":"Targeting KRAS in Pancreatic Cancer","volume":"12","author":"Cowzer","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jasc.2024.08.130_bib4","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.3390\/cancers15205015","article-title":"Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure","volume":"15","author":"de Jesus","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jasc.2024.08.130_bib5","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.3390\/cancers15174265","article-title":"Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma","volume":"15","author":"Chouari","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jasc.2024.08.130_bib6","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/1078-0432.CCR-17-3099","article-title":"Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations","volume":"24","author":"Hu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jasc.2024.08.130_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/gutjnl-2020-320726","article-title":"Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications","volume":"70","author":"Luchini","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jasc.2024.08.130_bib8","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1007\/s00018-018-2906-9","article-title":"Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches","volume":"75","author":"Ratti","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jasc.2024.08.130_bib9","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1159\/000531003","article-title":"The Day-To-Day Practice of MMR and MSI Assessment in Colorectal Adenocarcinoma: What We Know and What We Still Need to Explore","volume":"41","author":"Parente","year":"2023","journal-title":"Dig Dis"},{"key":"10.1016\/j.jasc.2024.08.130_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1158\/1078-0432.CCR-15-1678","article-title":"Microsatellite Instability as a Biomarker for PD-1 Blockade","volume":"22","author":"Dudley","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jasc.2024.08.130_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004485","article-title":"Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer","volume":"10","author":"Chakrabarti","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jasc.2024.08.130_bib12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/jclinpath-2020-207281","article-title":"DNA mismatch repair proteins: scientific update and practical guide","volume":"74","author":"Bateman","year":"2021","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jasc.2024.08.130_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/genes12010033","article-title":"Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer","volume":"12","author":"Ghidini","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.jasc.2024.08.130_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00535-019-01620-7","article-title":"Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers","volume":"55","author":"Eso","year":"2020","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jasc.2024.08.130_bib15","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jamasurg.2017.2631","article-title":"Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Patients With Pancreatic Ductal Adenocarcinoma","volume":"152","author":"Cloyd","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jasc.2024.08.130_bib16","first-page":"2536","article-title":"Prognostic value of microsatellite instability in resectable pancreatic cancer","volume":"8","author":"Nakata","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jasc.2024.08.130_bib17","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.5858\/arpa.2021-0632-CP","article-title":"Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer","volume":"146","author":"Bartley","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2024.08.130_bib18","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.22.02462","article-title":"Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline","volume":"41","author":"Vikas","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jasc.2024.08.130_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151552","article-title":"The utility of immunohistochemical testing for mismatch repair proteins in fine needle aspiration specimens of pancreatic adenocarcinoma","volume":"47","author":"Mettman","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.jasc.2024.08.130_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/PAI.0000000000000082","article-title":"CytoLyt\u00ae fixation and decalcification pretreatments alter antigenicity in normal tissues compared with standard formalin fixation","volume":"23","author":"Gruchy","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.jasc.2024.08.130_bib21","doi-asserted-by":"crossref","first-page":"viii36","DOI":"10.1093\/annonc\/mdz385","article-title":"Tumour response to TRK inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion","volume":"30","author":"O'Reilly","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jasc.2024.08.130_bib22","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1093\/oncolo\/oyad075","article-title":"A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas","volume":"28","author":"Demols","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.jasc.2024.08.130_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jclinpath-2021-207781","article-title":"Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature","volume":"76","author":"Allen","year":"2023","journal-title":"J Clin Pathol"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294524002011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294524002011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T13:15:19Z","timestamp":1731590119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294524002011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2213294524002011"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2024.08.130","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytologic testing for mismatch repair deficiency\/microsatellite instability and NTRK gene fusion is not routinely indicated in primary pancreaticobiliary carcinoma cell block material","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2024.08.130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society of Cytopathology.","name":"copyright","label":"Copyright"}]}}